This is a preview of subscription content, log in via an institution to check access.
Notes
2018 US dollars
Reference
Rens NE, et al. Cost-Effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active Tuberculosis. Clinical Infectious Diseases : 6 Jan 2020. Available from: URL: http://doi.org/10.1093/cid/ciz1212
Rights and permissions
About this article
Cite this article
Pharmacogenomic-guided isoniazid cost effective for drug-susceptible TB. PharmacoEcon Outcomes News 845, 26 (2020). https://doi.org/10.1007/s40274-020-6529-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6529-7